The Metaphyseal Hip Prosthesis - Total Hip

NCT01501955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-12-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to analyze stability, safety and efficacy of the Metaphyseal Hip Prosthesis (MHP) compared to the Stanmore hip replacement.

Conditions

  • Osteoarthritis of the Hip

Interventions

DEVICE

Metaphyseal Hip Prosthesis

Metaphyseal Hip Prosthesis (MHP) hip replacement

DEVICE

Stanmore

Stanmore hip prosthesis

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Stan Bell, MD · Bravis Ziekenhuis Roosendaal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-01-31
Completion
2023-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501955 on ClinicalTrials.gov